Back to results
US 2024/0164369 A1Published application
Mesenchymal stem cells for use in increasing ex-vivo organ life
AssigneeAmniotics AB
InventorsKåre Engkilde, Jan Talts, Sandra Lindstedt Ingemansson
Life of this patent
Estimating the term…
Abstract
The present invention relates to the field of mesenchymal stem cells and their use in ex-vivo organ preservation.
Claims23
A method for prolonging the ex vivo life of an ex vivo donor tissue and/or an ex vivo donor organ, said method comprising:
- providing an ex-vivo donor tissue and/or an ex-vivo donor organ, and
- contacting said ex-vivo donor tissue and/or ex-vivo donor organ with isolated term amniotic fluid (TAF) mesenchymal stem cells (MSCs) and/or a composition comprising isolated TAF MSCs.
2-24. (canceled)
A composition comprising isolated TAF MSCs, wherein the composition is selected from the group consisting of a conditioning media, perfusion fluid and injection fluid.
An ex-vivo organ perfusion system for conditioning an ex-vivo donor tissue and/or an ex-vivo donor organ, the system comprising:
- a system computing unit;
- a perfusion fluid circuit for a perfusion fluid;
- and
- a reservoir for containing an ex-vivo donor tissue and/or ex-vivo donor organ;
- wherein the system computing unit is operatively connected to the perfusion fluid circuit;
- wherein the system computing unit has at least one input;
- wherein the system computing unit is configured to receive a desired readout of at least one hemodynamic parameter;
- wherein the system computing unit is configured to receive an actual readout of at least one hemodynamic parameter;
- wherein the system computing unit is configured to control the perfusion fluid circuit so that the actual readout for the hemodynamic parameter(s) is driven towards its respective desired readout;
- and
- wherein the system is configured to receive isolated TAF MSCs.
8 more elements
Dependencies are inferred from the claim text.